![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 4.25 | ACUITE B | Downgraded | Issuer not co-operating* | - |
Bank Loan Ratings | 3.25 | - | ACUITE A4 | Reaffirmed | Issuer not co-operating* |
Total Outstanding | 7.50 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has downgraded the long-term rating to 'ACUITE B’ (read as ACUITE B) from ‘ACUITE B+’ (read as ACUITE B plus) and reaffirmed the short term rating of ‘ACUITE A4’ (read as ACUITE A four) on the Rs. 7.50 crore bank facilities of Danash Mand Organic Private Limited (DMOPL) on account of information risk. The rating continues to be flagged as "Issuer Not-Cooperating" and is based on the best available information. |
About the Company |
The Mumbai-based Danash Mand Organic Private Limited (DMOPL), incorporated in 1999, is engaged in the manufacturing of Pharma ingredients (API) at Roha (Maharashtra). The company manufactures Riboflavin-5-Phosphate Sodium, Metformin, Camphorquinone and Permethrin (Under process) to name a few. The company is led by Mrs Gurvinder Kaur (Managing Director) and Mr. Nagnath Govind Rao (Whole Time Director) with experience of two decades in the pharmaceuticals industry. |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies. |
Limitation regarding information availability |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 26.49 | 25.40 |
PAT | Rs. Cr. | 2.42 | 2.26 |
PAT Margin | (%) | 9.14 | 8.89 |
Total Debt/Tangible Net Worth | Times | 0.00 | 0.00 |
PBDIT/Interest | Times | 68.02 | 0.00 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |